The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier
Abstract
Several Na+-dependent carriers of amino acids exist on the abluminal membrane of the blood-brain barrier (BBB). These Na+-dependent carriers are in a position to transfer amino acids from the extracellular fluid of brain to the endothelial cells and thence to the circulation. To date, carriers have been found that may remove nonessential, nitrogen-rich, or acidic (excitatory) amino acids, all of which may be detrimental to brain function. We describe here Na+-dependent transport of large neutral amino acids across the abluminal membrane of the BBB that cannot be ascribed to currently known systems. Fresh brains, from cows killed for food, were used. Microvessels were isolated, and contaminating fragments of basement membranes, astrocyte fragments, and pericytes were removed. Abluminal-enriched membrane fractions from these microvessels were prepared. Transport was Na+ dependent, voltage sensitive, and inhibited by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid, a particular inhibitor of the facilitative large neutral amino acid transporter 1 (LAT1) system. The carrier has a high affinity for leucine (Km 21 +/- 7 microM) and is inhibited by other neutral amino acids, including glutamine, histidine, methionine, phenylalanine, serine, threonine, tryptophan, and tyrosine. Other established neutral amino acids may enter the brain by way of LAT1-type facilitative transport. The presence of a Na+-dependent carrier on the abluminal membrane capable of removing large neutral amino a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All essential AA are transported into the brain across the BBB via large neutral endothelial AA transporter 1 and 2 (LAT1/2) that transport bidirectionally large neutral AA such as tryptophan and tyrosine (450), and the cationic AA transporter 1 and 3 (CAT1/3)”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [450]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Ionic channels of excitable membranes
(1985) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(85)90172-7 · Cited by 7,134
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids
Fernstrom, J. D., & Wurtman, R. J. (1972) · Science · doi:10.1126/science.178.4059.414 · Cited by 1,166
Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., & Endou, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23629 · Cited by 1,109
Distinct Mediating Systems for the Transport of Neutral Amino Acids by the Ehrlich Cell
Oxender, D. L., & Christensen, H. N. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75327-7 · Cited by 834
Molecular Biology of Mammalian Plasma Membrane Amino Acid Transporters
Palacı́n, M., Estévez, R., Bertran, J., & Zorzano, A. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.969 · Cited by 821
The Concept of a Blood-Brain Barrier
(1980) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(80)90073-7 · Cited by 805
Amino acid assignment to one of three blood-brain barrier amino acid carriers
Oldendorf, W., & Szabo, J. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.230.1.94 · Cited by 594
Segawa, H., Fukasawa, Y., Miyamoto, K., Takeda, E., Endou, H., & Kanai, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19745 · Cited by 499
Cited by
Sorted by citations
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519
van Spronsen, F. J., Blau, N., Harding, C. O., Burlina, A., Longo, N., & Bosch, A. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00267-0 · Cited by 506
Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids
Hawkins, R. A., O’Kane, R. L., Simpson, I. A., & Viña, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.218s · Cited by 453
Self-citationPharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
del Amo, E. M., Urtti, A. O., & Yliperttula, M. L. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.015 · Cited by 318
In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
Naik, P. U., & Cucullo, L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23022 · Cited by 304
Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art
Karim, R., Palazzo, C., Évrard, B., & Piel, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.026 · Cited by 268
The blood–brain barrier in neurodegenerative disease: a rhetorical perspective
Carvey, P. M., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 260
Physiology and pharmacological role of the blood-brain barrier.
Bernacki, J., Dobrowolska, A., Nierwińska, K., & Małecki, A. (2008) · PubMed · Cited by 235
Transport of Amino Acids Across the Blood-Brain Barrier
Zaragozá, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00973 · Cited by 202
Pries, A. R., & Kuebler, W. M. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_1 · Cited by 197
Brain metastasis: Unique challenges and open opportunities
Lowery, F. J., & Yu, D. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.001 · Cited by 177
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 174
Lyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., Makrides, V., & Verrey, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.72 · Cited by 142
Polis, B., & Samson, A. O. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274328 · Cited by 142
The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2)
Bröer, A., Tietze, N., Kowalczuk, S., Chubb, S., Munzinger, M., Bak, L. K., & Bröer, S. (2005) · Biochemical Journal · doi:10.1042/bj20051273 · Cited by 134
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 127
Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+
O’Kane, R. L., Vinã, J. R., Simpson, I. A., Zaragozá, R., Mokashi, A. S., & Hawkins, R. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00007.2006 · Cited by 109
Self-citationCerebral effects of ammonia in liver disease: current hypotheses
Ott, P., & Vilstrup, H. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9494-7 · Cited by 106
The role of SLC transporters for brain health and disease
Nguyen, Y. T.-K., Ha, H. T. T., Nguyen, T. H., & Nguyen, L. N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04074-4 · Cited by 95
Sparrow, S. A., Manning, J. R., Cartier, J., Anblagan, D., Bastin, M. E., Piyasena, C., Pataky, R., Moore, E. J., Semple, S. I., Wilkinson, A. G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.210 · Cited by 88
Ryu, J. M., & Han, H. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216283 · Cited by 78
Hull, J., Hindy, M. E., Kehoe, P. G., Chalmers, K. A., Love, S., & Conway, M. E. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12044 · Cited by 72
Solute Carriers in the Blood–Brain Barier: Safety in Abundance
Nałęcz, K. A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2030-x · Cited by 69
Winn, S. R., Scherer, T., Thöny, B., Ying, M., Martı́nez, A., Weber, S. J., Raber, J., & Harding, C. O. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.10.009 · Cited by 65
Poustforoosh, A., Nematollahi, M. H., Hashemipour, H., & Pardakhty, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.015 · Cited by 62
Paley, E. L., Denisova, G. F., Sokolova, O. S., Posternak, N., Wang, X., & Brownell, A. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:9:1:55 · Cited by 58
ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications
Homaei, S. C., Halleland, H. B., Kleppe, R., Betari, N., Reif, A., & Haavik, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.012 · Cited by 58
Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
Davies, N. W. S., Guillemin, G. J., & Brew, B. J. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4321 · Cited by 57
Valdovinos-Flores, C., & Gonsebatt, M. E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.019 · Cited by 55
Savino, R., Carotenuto, M., Polito, A. N., Noia, S. D., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N., & Messina, G. (2020) · Brain Sciences · doi:10.3390/brainsci10090631 · Cited by 53
O’Kane, R. L., Vinã, J. R., Simpson, I. A., & Hawkins, R. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00187.2004 · Cited by 54
Self-citationNutrient Sensing by Hypothalamic Tanycytes
Elizondo-Vega, R. J., Recabal, A., & Oyarce, K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00244 · Cited by 51
BCAA Metabolism and NH3 Homeostasis
Conway, M. E., & Hutson, S. M. (2016) · Advances in Neurobiology · doi:10.1007/978-3-319-45096-4_5 · Cited by 53
Metabolic and Regulatory Roles of Leucine in Neural Cells
Murín, R., & Hamprecht, B. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9444-4 · Cited by 51
An active transport system in the blood–brain barrier may reduce levodopa availability
Hawkins, R. A., Mokashi, A. S., & Simpson, I. A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.04.008 · Cited by 52
Self-citationPhenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis
de Groot, M. J., Hoeksma, M., Reijngoud, D., de Valk, H. W., Paans, A. M. J., Sauer, P. J. J., & van Spronsen, F. J. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-133 · Cited by 50
Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products
Naik, P. U., & Cucullo, L. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0022-x · Cited by 48
Large neutral amino acids supplementation in phenylketonuric patients
Rocha, J. C., & Martel, F. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1132-x · Cited by 48
Evolution of serotonin: sunlight to suicide
Azmitia, E. C. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00001-3 · Cited by 42
Omidi, Y., Barar, J., Ahmadian, S., Heidari, H. R., & Gumbleton, M. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1455 · Cited by 40
Physical insights into the blood–brain barrier translocation mechanisms
Theodorakis, P. E., Müller, E. A., Craster, R. V., & Matar, O. K. (2017) · Physical Biology · doi:10.1088/1478-3975/aa708a · Cited by 40
Enzyme Complexes Important for the Glutamate–Glutamine Cycle
McKenna, M. C., & Ferreira, G. C. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_4 · Cited by 35
Berg, R. M. G., Taudorf, S., Bailey, D. M., Lundby, C., Larsen, F. S., Pedersen, B. K., & Møller, K. (2010) · Critical Care · doi:10.1186/cc8873 · Cited by 36
A model of dopamine and serotonin-kynurenine metabolism in cortisolemia: Implications for depression
Dalvi-Garcia, F., Fonseca, L. L., de Vasconcelos, A. T. R., Hedin‐Pereira, C., & Voit, E. O. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008956 · Cited by 34
Evolution of Serotonin: Sunlight to Suicide
Azmitia, E. C. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70069-2 · Cited by 31
Chemically induced model of hypermethioninemia in rats
Stefanello, F. M., Matté, C., Scherer, E. B. D. S., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.07.029 · Cited by 31
New insights into the role of the branched‐chain aminotransferase proteins in the human brain
Hull, J., Patel, V. B., Hutson, S. M., & Conway, M. E. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23558 · Cited by 30
Dysregulation of Astrocytic Glutamine Transport in Acute Hyperammonemic Brain Edema
Zielińska, M., Albrecht, J., & Popek, M. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.874750 · Cited by 26
Metabolic adaptations of brain metastasis
Parida, P. K., & Malladi, S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00848-1 · Cited by 28
Phenylketonuria: Brain Phenylalanine Concentrations Relate Inversely to Cerebral Protein Synthesis
de Groot, M. J., Sijens, P. E., Reijngoud, D., Paans, A. M. J., & van Spronsen, F. J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.183 · Cited by 25
Brain–blood amino acid correlates following protein restriction in murine maple syrup urine disease
Vogel, K. R., Arning, E., Wasek, B. L., McPherson, S., Bottiglieri, T., & Gibson, K. M. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-73 · Cited by 25
Delivery of Antihuman African Trypanosomiasis Drugs Across the Blood–Brain and Blood–CSF Barriers
Sekhar, G. N., Watson, C., Fidanboylu, M., Sanderson, L., & Thomas, S. A. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.003 · Cited by 25
Viggiano, A., Viggiano, E., Monda, M., Ingrosso, D., Perna, A. F., & Luca, B. D. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.048 · Cited by 24
Czeredys, M., Mysiorek, C., Kulikova, N., Samluk, Ł., Bérézowski, V., Cecchelli, R., & Nałęcz, K. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.122 · Cited by 23
Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer’s disease
Sharma, R., Razdan, K., Bansal, Y., & Kuhad, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1524877 · Cited by 22
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
Kolotyeva, N. A., Groshkov, A. A., Rozanova, N. A., Berdnikov, A. K., Novikova, S. V., Komleva, Y. K., Salmina, A. B., Illarioshkin, S. N., & Пирадов, М. А. (2024) · Biomolecules · doi:10.3390/biom14121556 · Cited by 24
Godyń, J., Gucwa, D., Kobrlová, T., Novak, M., Soukup, O., Malawska, B., & Bajda, M. (2020) · Talanta · doi:10.1016/j.talanta.2020.121023 · Cited by 21
Michalec, K., Mysiorek, C., Kuntz, M., Bérézowski, V., Szczepankiewicz, A. A., Wilczynski, G. M., Cecchelli, R., & Nałęcz, K. A. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.006 · Cited by 21
Roberts, E. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_7 · Cited by 21
Wang, X.-X., Hu, Y., Keep, R. F., Toyama‐Sorimachi, N., & Smith, D. E. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.012 · Cited by 17
Zetterling, M., Hillered, L., Samuelsson, C., Karlsson, T., Enblad, P., & Ronne-Engström, E. (2009) · Acta Neurochirurgica · doi:10.1007/s00701-009-0384-4 · Cited by 18
Mechanisms and Significance of the Increased Brain Uptake of Tryptophan
Lenard, N. R., & Dunn, A. J. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8832-x · Cited by 18
Current Advances and Material Innovations in the Search for Novel Treatments of Phenylketonuria
Delbreil, P., Dhondt, S., Rahbani, R. M. K. E., Banquy, X., Mitchell, J. J., & Brambilla, D. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401353 · Cited by 17
Changes in kinetics of amino acid uptake at the ageing ovine blood–cerebrospinal fluid barrier
Chen, R. L., & Preston, J. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.015 · Cited by 14
Rochfort, K. D., & Cummins, P. M. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_5 · Cited by 16
Guebel, D. V., & Torres, N. V. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.05.005 · Cited by 14
Sørensen, M., Andersen, J. V., Bjerring, P. N., & Vilstrup, H. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01473-x · Cited by 13
Shi, Y., Ding, D., Liu, L., Li, Z., Zuo, L., Zhou, L., Du, Q., Jing, Z., Zhang, X., & Sun, Z. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00697 · Cited by 13
Iakovou, K., & Schulpis, K. (2019) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2018-0233 · Cited by 8
Transport at the Blood–Brain Barrier
Neuhaus, W., & Noe, C. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627424.ch10 · Cited by 16
Taslimifar, M., Faltys, M., Kurtcuoglu, V., Verrey, F., & Makrides, V. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211039593 · Cited by 10
Silva, E., Gomes, P., & Soares-da-Silva, P. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.018 · Cited by 10
Chiong, M. A. D., Tan, M. A., Cordero, C. P., Fodra, E. G. D., Manliguis, J. S., Lopez, C. P., & Dalmacio, L. M. M. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.10.004 · Cited by 10
Liempd, S. M. V., Cabrera, D., Lee, F. Y., González, E., Dell’Angelica, E. C., Ghiani, C. A., & Falcón‐Pérez, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05465-z · Cited by 10
Brust, P., Vorwieger, G., Walter, B. L., Füchtner, F., Stark, H., Kuwabara, H., Herzau, M., Opfermann, T., Steinbach, J., Ganapathy, V., et al. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.07.002 · Cited by 10
Witt, A. M., Larsen, F. S., & Bjerring, P. N. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9934-7 · Cited by 9
Orrico‐Sánchez, A., Guiard, B. P., Manta, S., Callebert, J., Launay, J., Louis, F., Paccard, A., Gruszczynski, C., Betancur, C., Vialou, V., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02596-y · Cited by 9
Ajayi, E. D., Elazazy, M., Abouzid, K. A. M., & Ali, H. I. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118219 · Cited by 9
The Blood-Brain Barrier in Epilepsy
Bauer, B., Schlichtiger, J., Pekcec, A., & Anika, M. S. (2011) · InTech eBooks · doi:10.5772/21561 · Cited by 7
Ziadlou, M., & MacDonald, A. (2022) · JIMD Reports · doi:10.1002/jmd2.12327 · Cited by 6
Blood-Brain Barrier and Cognitive Function
Zăgrean, A., Ianosi, B., Șonea, C., Opriș, I. C., & Zăgrean, L. (2017) · Springer series in cognitive and neural systems · doi:10.1007/978-3-319-29674-6_32 · Cited by 5
Blood-Brain Barrier Dysfunction in the Detrimental Brain Function
González‐Candia, A., Rogers, N. K., & Castillo, R. L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94572 · Cited by 5
Amino Acid Transport Across the Blood—Brain Barrier
Smith, Q. R., Mandula, H., & Parepally, J. M. R. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50200-2 · Cited by 5
Brito, E. M., Baker, E. M., Ahye, N. M., Lieber, B. A., Hettiarachchi, S. D., Hollweg, M. J. M., Safar, S. B., Vanni, S., & Graham, R. M. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00810-9 · Cited by 4
Kreis, R. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_40 · Cited by 3
Chemically induced acute model of sarcosinemia in wistar rats
de Andrade, R. B., Gemelli, T., Rojas, D. B., Dutra‐Filho, C. S., & Wannmacher, C. M. D. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9759-9 · Cited by 3
Dahl, R. H., Berg, R. M. G., Taudorf, S., Bailey, D. M., Lundby, C., Christensen, M., Larsen, F. S., & Møller, K. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1683762 · Cited by 3
Rochfort, K. D., & Cummins, P. M. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_3 · Cited by 2
Phenylketonuria: modelling cerebral amino acid and neurotransmitter metabolismPreprint
Wegrzyn, A. B., van Vliet, D., van Eunen, K., Heiner-Fokkema, M. R., van der Zee, E. A., van Spronsen, F. J., & Bakker, B. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.05.574352 · Cited by 2
Branched-Chain Amino Acids and Brain Metabolism
Hamprecht, B., & Murín, R. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch28 · Cited by 1
Nimjee, S. M., Grant, G. A., Winn, H. R., & Janigro, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00009-5 · Cited by 1
Harder, A. V. E., van Klinken, J. B., van Dongen, R. M., Onderwater, G. L. J., Ferrari, M. D., Harms, A. C., Hankemeier, T., Terwindt, G. M., & van den Maagdenberg, A. M. J. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209899 · Cited by 1
Nutritional modulation of the “brain–;gut axis”
Brummer, R. J. (2005) · Scandinavian Journal of Nutrition · doi:10.1080/11026480510038074 · Cited by 1
Weil, R. J., & Oldfield, E. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00010-1 · Cited by 1
Panula, P. (2007) · Springer eBooks · doi:10.1007/978-0-387-30373-4_3 · Cited by 1
EXPRESSION PROFILING OF BLOOD VESSELS IN PERICYTE DEFICIENCY AND DIABETES
Norlin, J. (2010) · Figshare · Cited by 1
Yu, K. O., Mahle, D. A., Robinson, P. J., Narayanan, L., Gearhart, J. M., & Lobo‐Menendez, F. (2015)
Metadata
- Authors
- O'Kane, R. L., & Hawkins, R. A.
- Affiliations
- Department of Physiology and Biophysics, Finch University of Health Sciences/The Chicago Medical School, North Chicago, Illinois 60064
- Rosalind Franklin University of Medicine and Science (US)
- ORCID
- Hawkins, Richard A.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2003-12
- Volume
- 285
- Issue
- 6
- Pages
- E1167-E1173
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2141267676
- Cited by
- 105
- References
- 55
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 8 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 10 · 2015: 6 · 2014: 5 · 2013: 1 · 2012: 3
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS041405, NS-041405)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, Na+-dependent amino acid transport, large neutral amino acids, LAT1, amino acid transporters, leucine, essential amino acids, excitatory amino acids, endothelial cells
- MeSH terms
- Amino Acids, Essential, Animals, Biological Transport, Active, Blood-Brain Barrier, Capillary Permeability, Cattle, Cell Membrane, Cell Membrane Permeability, Cells, Cultured, Endothelium, Vascular, Sodium, Extracellular Fluid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review